Mitochondrial Dysfunction in Chronic Kidney Disease
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Icatibant (Primary)
- Indications Mitochondrial disorders
- Focus Therapeutic Use
- Acronyms MitoCKD
- 03 Apr 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2017 Status changed from not yet recruiting to active, no longer recruiting.